Gastric secretion and peptic ulceration in cirrhosis (Q40811158)

23 September 2017

1 reference

title

Gastric secretion and peptic ulceration in cirrhosis (English)

1 reference

23 September 2017

Fraser AG

1

1 reference

23 September 2017

Pounder RE

series ordinal

2

1 reference

23 September 2017

Burroughs AK

series ordinal

3

1 reference

23 September 2017

publication date

1 August 1993

1 reference

23 September 2017

published in

Journal of Hepatology

1 reference

23 September 2017

volume

19

1 reference

23 September 2017

issue

1

1 reference

23 September 2017

page(s)

171-182

1 reference

AN ASSESSMENT OF THE AUGMENTED HISTAMINE TEST IN THE DIAGNOSIS OF PEPTIC ULCER. CORRELATIONS BETWEEN GASTRIC SECRETION, AGE AND SEX OF PATIENTS, AND SITE AND NATURE OF THE ULCER.

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980191-6

7 January 2021

Relationship between insulin sensitivity, insulin secretion and glucose tolerance in cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980191-6

7 January 2021

Twenty-four hour intragastric acidity and plasma gastrin concentration profiles in female and male subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980191-6

7 January 2021

Reduction of gastric acid secretion on a low-salt diet and furosemide

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980191-6

7 January 2021

Diuretics suppress acid secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980191-6

7 January 2021

Hypergastrinaemia in cirrhosis of liver

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980191-6

7 January 2021

REDUCED GASTRIC ACID OUTPUT IN CIRRHOSIS: QUANTITATION AND RELATIONSHIPS.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980191-6

7 January 2021

Gastric secretion in cirrhosis and non-cirrhotic portal fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980191-6

7 January 2021

Gastric mucosal prostaglandin E2 levels in cirrhosis and portal hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980191-6

7 January 2021

PEPTIC ULCER AND GASTRIC SECRETION IN PATIENTS WITH LIVER DISEASE.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980191-6

7 January 2021

Intestinal phase of gastric acid secretion in humans with and without portacaval shunt

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980191-6

7 January 2021

Increased sensitivity of gastric acid secretion to gastrin in cirrhotic patients with portacaval shunt

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980191-6

7 January 2021

Normal Serum Gastrin Levels in Patients with Liver Cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980191-6

7 January 2021

Chronobiological study on serum innumoreactive gastrin RIA levels in patients with liver cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980191-6

7 January 2021

Enhanced hyperplasia of gastric enterochromaffinlike cells in response to omeprazole-evoked hypergastrinemia in rats with portacaval shunts. An immunocytochemical and chemical study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980191-6

7 January 2021

Peptic ulcer: the many proteinases of aggression.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980191-6

7 January 2021

Elevated serum pepsinogen I and II levels differ as risk factors for duodenal ulcer and gastric ulcer

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980191-6

7 January 2021

Endogenous prostaglandin E2 in gastric mucosa of patients with alcoholic cirrhosis and portal hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980191-6

7 January 2021

Gastric vascular ectasias in cirrhosis: association with hypoacidity not related to gastric atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980191-6

7 January 2021

Gastric mucosal vascular ectasias causing bleeding in cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980191-6

7 January 2021

Gastric lesions in portal hypertension: inflammatory gastritis or congestive gastropathy?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980191-6

7 January 2021

The gastric mucosa in portal hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980191-6

7 January 2021

Microvascular abnormalities of the portal hypertensive gastric mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980191-6

7 January 2021

Snake skin pattern gastropathy in cirrhotic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980191-6

7 January 2021

Clinical features, pathophysiology and relevance of portal hypertensive gastropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980191-6

7 January 2021

Gastroesophageal endoscopic features in cirrhosis: comparison of intracenter and intercenter observer variability.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980191-6

7 January 2021

Endoscopic and histologic appearance of the gastric mucosa in patients with portal hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980191-6

7 January 2021

Neuroendocrine cell proliferations in gastric antral vascular ectasia

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980191-6

7 January 2021

The stomach in liver cirrhosis. Endoscopic, morphological, and clinical correlations

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980191-6

7 January 2021

Gastric mucosal blood flow and acid secretion in portal hypertensive rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980191-6

7 January 2021

Effects of propranolol on gastric microcirculation and acid secretion in portal hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980191-6

7 January 2021

Gastric Mucosal Blood Flow Response to Stimulation and Inhibition of Gastric Acid Secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980191-6

7 January 2021

Endogenous nitric oxide as a mediator of gastric mucosal vasodilatation during acid secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980191-6

7 January 2021

Gastric emptying of liquids and solids in the portal hypertensive rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980191-6

7 January 2021

Circulatory mechanisms of gastric mucosal damage and protection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980191-6

7 January 2021

Impaired oxygenation of gastric mucosa in portal hypertension. The basis for increased susceptibility to injury

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980191-6

7 January 2021

Peptic ulceration in patients with chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980191-6

7 January 2021

Frequency of upper gastrointestinal lesions in patients with liver cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980191-6

7 January 2021

Silent peptic ulceration: deadly silence or golden silence?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980191-6

7 January 2021

Combined upper and lower gastrointestinal endoscopy: a prospective study in alcoholic and nonalcoholic cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980191-6

7 January 2021

Prevalence of duodenal ulcer in cirrhotic males referred for liver transplantation. Does the etiology of cirrhosis make a difference?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980191-6

7 January 2021

Upper gastrointestinal endoscopy in normal asymptomatic volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980191-6

7 January 2021

Does maintenance therapy keep duodenal ulcers healed?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980191-6

7 January 2021

Gastro-oesophageal reflux and alcoholic cirrhosis. A reappraisal.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980191-6

7 January 2021

Prolonged ambulatory pH monitoring in patients following oesophageal transection and control subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980191-6

7 January 2021

Bleeding from staple line erosion after esophageal transection: effect of omeprazole

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980191-6

7 January 2021

Omeprazole in the management of intractable esophageal ulceration following injection sclerotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980191-6

7 January 2021

Total 24-hour gastric acid secretion in patients with duodenal ulcer. Comparison with normal subjects and effects of cimetidine and parietal cell vagotomy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980191-6

7 January 2021

Detailed comparison of basal and food-stimulated gastric acid secretion rates and serum gastrin concentrations in duodenal ulcer patients and normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980191-6

7 January 2021

Campylobacter pylori and peptic ulcer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980191-6

7 January 2021

Cure of duodenal ulcer associated with eradication of Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980191-6

7 January 2021

Inappropriate hypergastrinaemia in asymptomatic healthy subjects infected with Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980191-6

7 January 2021

Eradication of Helicobacter pylori abolishes 24-hour hypergastrinaemia: a prospective study in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980191-6

7 January 2021

Congestive gastropathy and Helicobacter pylori: an endoscopic and morphometric study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980191-6

7 January 2021

Natural history of congestive gastropathy in cirrhosis. The Liver Study Group of V. Cervello Hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980191-6

7 January 2021

Gastric mucosa in patients with portal hypertension: prevalence of capillary dilatation and Campylobacter pylori

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980191-6

7 January 2021

Cigarettes, alcohol, coffee and peptic ulcer.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980191-6

7 January 2021

Effect of intragastric infusions of ethanol and wine on serum gastrin concentration and gastric acid secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980191-6

7 January 2021

Alcohol and the gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980191-6

7 January 2021

Histologic and morphometric study of chronic gastritis in alcoholic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980191-6

7 January 2021

Campylobacter pylori in alcoholic hemorrhagic "gastritis"

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980191-6

7 January 2021

Increased susceptibility of the portal hypertensive gastric mucosa to damage

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980191-6

7 January 2021

Taurocholate induced gastric mucosal injuries in experimental portal hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980191-6

7 January 2021

Propranolol reduces ethanol-induced gastric mucosal damage in portal hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980191-6

7 January 2021

Cimetidine kinetics and dynamics in patients with severe liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980191-6

7 January 2021

Effects of cirrhosis and ageing on the elimination and bioavailability of ranitidine

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980191-6

7 January 2021

Is there an optimal degree of acid suppression for healing of duodenal ulcers? A model of the relationship between ulcer healing and acid suppression

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980191-6

7 January 2021

Refractory duodenal ulcers (nonhealing duodenal ulcers with standard doses of antisecretory medication)

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980191-6

7 January 2021

Frequent non-response to histamine H2-receptor antagonists in cirrhotics

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980191-6

7 January 2021

Review article: maintenance treatment with H2-receptor antagonists for peptic ulcer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980191-6

7 January 2021

A randomized study of maintenance therapy with ranitidine to prevent the recurrence of duodenal ulcer

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980191-6

7 January 2021

The anti-secretory effect and pharmacokinetics of omeprazole in chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980191-6

7 January 2021

Effect of omeprazole on nocturnal intragastric pH in cirrhotics with inadequate antisecretory response to ranitidine

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980191-6

7 January 2021

Royal Free Hospital protocol for 24-hour intragastric acidity and plasma gastrin concentration

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980191-6

7 January 2021

10.1016/S0168-8278(05)80191-6

Identifiers

DOI

1 reference

23 September 2017

1 reference